Letter to the Editor: Microplastics as promoters of metabolic dysfunction-associated steatotic liver disease: Mechanistic insights and implications
World Journal of Hepatology · 27.06.2026 · 18 (6)
DOI: 10.4254/wjh.118615 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Hepatology, online erschienen am 27.06.2026. Verfasst von Nabil Eid. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide and carries a substantial risk of progression to hepatocellular carcinoma. The detection of microplastics (MPs) in human tissues - including the brain, lung, liver, and blood - has emerged as an important environmental health concern. A recent study comprehensively summarized the potential mechanisms by which MPs may induce and exacerbate MASLD. The evidence discussed was largely derived from in vitro and preclinical studies and included hepatic lipid dysregulation, oxidative and endoplasmic reticulum stress, mitochondrial dysfunction, inflammatory signaling, fibrogenesis, gut dysbiosis, and endocrine disruption. This article comments on the study by Rajak et al , published in the recent issue of the World Journal of Hepatology , and specifically highlights how MPs-induced autophagy dysfunction may contribute to MASLD progression and its potential clinical implications.
Zitieren
APA
Eid, N. (2026). Letter to the Editor: Microplastics as promoters of metabolic dysfunction-associated steatotic liver disease: Mechanistic insights and implications. World Journal of Hepatology, 18(6). https://doi.org/10.4254/wjh.118615
Vancouver
Eid N. Letter to the Editor: Microplastics as promoters of metabolic dysfunction-associated steatotic liver disease: Mechanistic insights and implications. World Journal of Hepatology. 2026;18(6). doi:10.4254/wjh.118615
BibTeX
@article{Eid2026,
author = {Eid, Nabil},
title = {Letter to the Editor: Microplastics as promoters of metabolic dysfunction-associated steatotic liver disease: Mechanistic insights and implications},
journal = {World Journal of Hepatology},
year = {2026},
volume = {18},
number = {6},
doi = {10.4254/wjh.118615}
}
EUVIMED